• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. PLASMAFLO OP; PLASMA SEPARATOR Back to Search Results
Model Number OP-05W(A)
Device Problem Patient-Device Incompatibility (2682)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/19/2019
Event Type  Death  
Manufacturer Narrative
This incident occurred in (b)(6) and is reported to fda according to the requirement.Op-05w is identical model to op-05w(a) marketed in u.S.The product in complaint was not returned to the manufacturer and could not be analyzed.The lot number in complaint was not reported and we could not review the manufacturing and quality control records.According to the physician comment about the relationship between this product and the patient's death, this treatment of op and prasorba brs might have caused the patient's early death.We judged that this case as serious adverse event because the outcome is death.The causal relationship between these events and op are not denied because the patient's clinical laboratory data were aggravated after the treatment, and that this patient died 6 hours after the end of the treatment.This case information was derived from the inquiry from the customer, so follow-up information about the cause of the death could not be obtained.The caution as to the patients with low platelet count is written in the ifu as follows.In the "e.Precautions", as "15.The plasmaflo¿ op-05w(a) is not recommended for use with the following patients, except where specifically approved by and used in accordance with the directions of the responsible physician.Patients with low platelet count" however, "platelet count decreased, prothrombin time prolonged" is not written in the ifu, but this case is their first adverse events for us to receive, we will continue to monitor the occurrence of these kinds of events.
 
Event Description
This case occurred in the facility of (b)(6).On (b)(6) 2019: the level of this patient's blood pressure was low from the morning, and the patient's aspiration was managed with the ventilator before bilirubin adsorption treatment.This patient was treated with bilirubin adsorption treatment of plasmaflo op-05w used as plasma separator and similar product of op-05w(a) sold in us, and plasorba brs, absorptive removal column of bilirubin and bile acid, to absorb bilirubin.Patient's platelet count decreased from 116,000/ul to 102,000/ul.Prothrombin time increased from 15.6 seconds to 22.5 seconds.On (b)(6) 2019: this patient was treated with bilirubin adsorption therapy.Platelet count decreased from 102,000 /ul to 82,000 /ul.Prothrombin time increased from 19.1 seconds to 29 seconds.13:25, the treatment with bilirubin adsorption therapy was stopped.No bleeding around the catheter at the vascular access of the groin.19:18, this patient has died.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PLASMAFLO OP
Type of Device
PLASMA SEPARATOR
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP.
oita works
2111-2 oaza sato
oita-shi, oita 870-0 396
JA   870-0396
Manufacturer Contact
akitake yamashita
1-1-2 yurakucho, chiyoda-ku
tokyo 100-0-006
JA   100-0006
MDR Report Key8525799
MDR Text Key142320346
Report Number8010002-2019-00040
Device Sequence Number1
Product Code MDP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P820033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model NumberOP-05W(A)
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
PLASORBA BRS
Patient Outcome(s) Death;
-
-